Publication | Open Access

Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation

Signal TransductionAutoimmune DiseaseAllergyAutoantibody ProductionImmune Cell DevelopmentMedicineT-regulatory CellImmune RegulationImmunologyRuxolitinib ReversesAutoimmunityTolerance InductionNovel Signal TransducerCellular Immune ResponseImmunotherapyTranscription 1Cell SignalingImmune Dysregulation